BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6592972)

  • 1. Penicillamine-induced myositis. Observations and unique features in two patients and review of the literature.
    Halla JT; Fallahi S; Koopman WJ
    Am J Med; 1984 Oct; 77(4):719-22. PubMed ID: 6592972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penicillamine induced polymyositis and dermatomyositis.
    Carroll GJ; Will RK; Peter JB; Garlepp MJ; Dawkins RL
    J Rheumatol; 1987 Oct; 14(5):995-1001. PubMed ID: 3501473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penicillamine-induced polymyositis-dermatomyositis.
    Petersen J; Halberg P; Højgaard K; Lyon BB; Ullman S
    Scand J Rheumatol; 1978; 7(2):113-7. PubMed ID: 705267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features.
    Delamere JP; Jobson S; Mackintosh LP; Wells L; Walton KW
    Ann Rheum Dis; 1983 Oct; 42(5):500-4. PubMed ID: 6605118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatomyositis induced by penicillamine.
    Simpson NB; Golding JR
    Acta Derm Venereol; 1979; 59(6):543-4. PubMed ID: 94219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penicillamine-induced dermatomyositis. A case history.
    Lund HI; Nielsen M
    Scand J Rheumatol; 1983; 12(4):350-2. PubMed ID: 6658398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatomyositis complicating penicillamine treatment.
    Fernandes L; Swinson DR; Hamilton EB
    Ann Rheum Dis; 1977 Feb; 36(1):94-5. PubMed ID: 843119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis.
    Bardin T; Dryll A; Debeyre N; Ryckewaert A; Legrand L; Marcelli A; Dausset J
    Ann Rheum Dis; 1982 Dec; 41(6):599-601. PubMed ID: 6959574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dermatopolymyositis induced by D-penicillamine in rheumatoid polyarthritis. Apropos of 1 case with review of the literature].
    Kolsi R; Bahloul Z; Hachicha J; Gouiaa R; Jarraya A
    Rev Rhum Mal Osteoartic; 1992 May; 59(5):341-4. PubMed ID: 1411195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA and disease manifestations in rheumatoid arthritis--a Canadian experience.
    Gladman DD; Anhorn KA
    J Rheumatol; 1986 Apr; 13(2):274-6. PubMed ID: 3459890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-penicillamine-induced polymyositis occurring in patients with rheumatoid arthritis: a report of two cases and demonstration of a positive lymphocyte stimulation test to D-penicillamine.
    Matsumura T; Yuhara T; Yamane K; Kono I; Kabashima T; Kashiwagi H
    Henry Ford Hosp Med J; 1986; 34(2):123-6. PubMed ID: 3489699
    [No Abstract]   [Full Text] [Related]  

  • 12. Penicillamine-induced proteinuria: risk factors.
    Stein HB; Schroeder ML; Dillon AM
    Semin Arthritis Rheum; 1986 May; 15(4):282-7. PubMed ID: 3487119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
    Garlepp MJ; Dawkins RL; Christiansen FT
    Br Med J (Clin Res Ed); 1983 Jan; 286(6362):338-40. PubMed ID: 6402089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatomyositis induced by penicillamine.
    Wojnarowska F
    J R Soc Med; 1980 Dec; 73(12):884-6. PubMed ID: 7452649
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic lupus erythematosus during penicillamine therapy for rheumatoid arthritis.
    Chalmers A; Thompson D; Stein HE; Reid G; Patterson AC
    Ann Intern Med; 1982 Nov; 97(5):659-63. PubMed ID: 6958210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between aurothioglucose- and D-penicillamine-induced proteinuria.
    Speerstra F; van de Putte LB; Rasker JJ; Reekers P; Vandenbroucke JP
    Scand J Rheumatol; 1984; 13(4):363-8. PubMed ID: 6441248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA DR antigens and disease expression in rheumatoid arthritis.
    Griffin AJ; Wooley P; Panayi GS; Batchelor JR
    Ann Rheum Dis; 1984 Apr; 43(2):218-21. PubMed ID: 6424587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penicillamine-induced myositis in rheumatoid arthritis.
    Morgan GJ; McGuire JL; Ochoa J
    Muscle Nerve; 1981; 4(2):137-40. PubMed ID: 7207503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens.
    Moens HJ; Ament BJ; Feltkamp BW; van der Korst JK
    J Rheumatol; 1987 Dec; 14(6):1115-9. PubMed ID: 3437418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.